Close Menu

This article has been updated with additional information from Bionano's earnings call.

NEW YORK (GenomeWeb) – Bionano Genomics reported after the close of the market on Thursday a 41 percent year-over-year increase in its fourth quarter revenues, the company's first full quarter as a publicly traded firm.

Separately, the firm said it has entered into two separate debt and equity financing agreements totaling $41.5 million with Innovatus Life Sciences Lending Fund, East West Bank, and Aspire Capital.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.